Dataset from A Randomized, Double Blind, (Test Products), Chronic Dosing (7 Days), Four Period, Eight Treatment , Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Five Doses of PT003, One Dose of PT001 and One Dose of PT005 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open Label) as Active Control
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006923
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to assess the efficacy of Glycopyrrolate/Formoterol
Fumarate MDI relative to individual components (GP MDI and FF MDI) in subjects with moderate
to severe COPD
创建时间：
2025-09-02
